<DOC>
	<DOCNO>NCT00211354</DOCNO>
	<brief_summary>Retinal Vein Occlusion blockage blood vessel drain retina . Complications retinal vein occlusion threaten vision include neovascularization ( growth new blood vessel ) macular edema ( accumulation fluid `` leaking '' abnormal blood vessel ) . Currently , treatment retinal vein occlusion laser photocoagulation . This treatment find limited use type condition.Anecortave Acetate consider attempt control growth abnormal blood vessel .</brief_summary>
	<brief_title>Treatment Retinal Vein Occlusion ( RVO ) With Open-Label Anecortave Acetate ( 15mg . )</brief_title>
	<detailed_description />
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Anecortave</mesh_term>
	<criteria>1 . Clinical diagnosis patient Retinal Vein Occlusion . 2 . Patients must 18 year age older receive treatment . 3 . Visual acuity 20/30 20/320 Study Eye ETDRS visual acuity chart . 4 . Visual acuity 20/800 good Fellow Eye ETDRS visual acuity chart . 1 . Patient significantly compromise visual acuity study eye due concomitant ocular condition . 2 . Patients undergone intraocular surgery within last 2 month . 3 . Patient participate investigational drug study . 4 . Use investigational drug treatment relate unrelated condition within 30 day prior receipt study medication . 5 . Inability obtain photographs document CNV ( include difficulty venous access ) . 6 . Patient significant liver disease uremia . 7 . Patient known adverse reaction fluorescein indocyanine green iodine . 8 . Patient history medical condition would preclude schedule visit completion study . 9 . Patient insertion scleral buckle study eye . 10 . Patient receive radiation treatment . 11 . Patient anticoagulant therapy exception aspirin . 12 . Patient pregnant nursing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>